Friedlander, M <br/><br/>
Definition of two angiogenic pathways by distinct alpha v integrins.  [electronic resource] 

 -  Science (New York, N.Y.)  Dec 1995 
 - 1500-2 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0036-8075 
<br/><br/><label>Standard No.: </label>10.1126/science.270.5241.1500  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal<br/>Chick Embryo<br/>Cornea--blood supply<br/>Endothelial Growth Factors--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Integrins--immunology<br/>Lymphokines--pharmacology<br/>Naphthalenes--pharmacology<br/>Neovascularization, Pathologic<br/>Neovascularization, Physiologic--drug effects<br/>Peptides, Cyclic--pharmacology<br/>Protein Kinase C--antagonists & inhibitors<br/>Rabbits<br/>Receptors, Vitronectin--immunology<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Transforming Growth Factor alpha--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors